14 reports

WHILE AT NIMH, HIS AREA OF RESEARCH WAS FOCUSING ON THE NEUROBIOLOGY OF DEPRESSION AND BIPOLAR DISORDER.

  • Endoscopic Device
  • Australasia
  • Australia
  • Oceania
  • Medtronic, Inc.

IN ADDITION TO ASSESSING ESTABLISHED RISK FACTORS, THE ALGORITHM NOW TAKES INTO ACCOUNT NEW RISK FACTORS INCLUDING: ATYPICAL ANTIPSYCHOTICS, STATINS, SCHIZOPHRENIA OR BIPOLAR AFFECTIVE DISORDER, LEARNING DISABILITY, GESTATIONAL DIABETES, AND POLYCYSTIC OVARY SYNDROME.

  • Endoscopic Device
  • Type 2 Diabetes
  • Northern Europe
  • United Kingdom
  • Market Size
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2017 (CONTD..7), H2 2017

IT WAS ALSO UNDER DEVELOPMENT FOR MOOD DISORDER AND BIPOLAR DISORDER.

  • Obesity
  • Pharmaceutical
  • Therapy
  • Type 2 Diabetes
  • Omeros Corporation

WHILE AT NIMH, HIS AREA OF RESEARCH WAS FOCUSING ON THE NEUROBIOLOGY OF DEPRESSION AND BIPOLAR DISORDER.

  • Endoscopic Device
  • Type 2 Diabetes
  • Australasia
  • Australia
  • Oceania

The company' s product pipeline comprises DUR-## indicated for treatment of acute organ injuries and metabolic/ lipid disorders; Remoxy, indicated for chronic pain; Posimir, indicated for post-operative pain; Eladur, indicated for post herpetic neuralgia; Oradur, indicated for chro

  • Diabetes
  • Type 2 Diabetes
  • United States
  • Company
  • Product Initiative
  • Glycogen Synthase Kinase 3 Beta (GSK-3 Beta or EC 2.7.11.26) - Dormant Projects

Neurim mainly specializes on age-related disorders.

  • Type 2 Diabetes
  • United States
  • World
  • Product Initiative
  • DiaMedica Inc.

The company' s product pipeline comprises DUR-## indicated for treatment of acute organ injuries and metabolic/ lipid disorders; Remoxy, indicated for chronic pain; Posimir, indicated for post-operative pain; Eladur, indicated for post herpetic neuralgia; Oradur, indicated for chro

  • Cell Therapy
  • Type 2 Diabetes
  • United States
  • Company
  • Product Initiative

Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale metaanalysis.

  • Chronic Disease
  • Diabetes
  • Insulin
  • Type 2 Diabetes
  • Deals & Alliance

The company' s product pipeline comprises DUR-## indicated for treatment of acute organ injuries and metabolic/ lipid disorders; Remoxy, indicated for chronic pain; Posimir, indicated for post-operative pain; Eladur, indicated for post herpetic neuralgia; Oradur, indicated for chro

  • Digestive System Disorder
  • Type 2 Diabetes
  • United States
  • Company
  • Product Initiative

The company' s product pipeline comprises DUR-## indicated for treatment of acute organ injuries and metabolic/ lipid disorders; Remoxy, indicated for chronic pain; Posimir, indicated for post-operative pain; Eladur, indicated for post herpetic neuralgia; Oradur, indicated for chro

  • Chronic Disease
  • Genitourinary System Disease
  • Pharmaceutical
  • Type 2 Diabetes
  • Product Initiative

Ltd. registered a Phase I dose block-randomized, double-blind, placebo-controlled, single dose, dose-escalation study to investigate the safety, tolerance, pharmacokinetics and pharmacodynamics of tolvaptan in healthy Korean male subjects bipolar disorder.

  • Chronic Disease
  • Genitourinary System Disease
  • Type 2 Diabetes
  • United States
  • Product Initiative
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2016 (CONTD..7)

Reviva Pharma' s product RP## is also been developing for Parkinson' s psychosis (PDP), attention deficit hyperactivity disorder (ADD/ ADHD), bipolar disorder, major depressive disorder (MDD), Alzheimer' s psychosis/ agitation (ADP), and auti

  • Pharmaceutical
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Company
  • Product Initiative

The company' s product pipeline comprises DUR-## indicated for treatment of acute organ injuries and metabolic/ lipid disorders; Remoxy, indicated for chronic pain; Posimir, indicated for post-operative pain; Eladur, indicated for post herpetic neuralgia; Oradur, indicated for chro

  • Pharmaceutical
  • Therapy
  • Type 2 Diabetes
  • United States
  • Product Initiative

It covers the methods of treating diseases mediated by PDE##, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.

  • Blood Disease
  • Monoclonal Antibody
  • Therapy
  • Type 2 Diabetes
  • Amgen Inc.